Evidence map›Paper›PMID 41358039›Full record

ArticleThe mental health clinician2025

Clinical pearls for the treatment of narcolepsy.

Marilyn N Bulloch, James D Geyer

Abstract read
In one paragraph

Article in The mental health clinician, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marilyn N Bulloch(Corresponding author) Associate Clinical Professor, Auburn University Harrison College of Pharmacy, Auburn, Alabama; Adjunct Associate Professor, University of Alabama College of Community Health Sciences, Tuscaloosa, Alabama; Adjunct Associate Professor, University of Alabama-Birmingham Heersink School of Medicine, Birmingham, Alabama, mjn0004@auburn.edu.ORCID https://orcid.org/0000-0001-6044-3100
James D GeyerProfessor, University of Alabama College of Community Health Sciences, Tuscaloosa, Alabama; Medical Director, Institute for Rural Health Research, Tuscaloosa, Alabama; Adjunct Professor, University of Alabama-Birmingham Heersink School of Medicine, Birmingham, Alabama.ORCID https://orcid.org/0000-0002-2776-1737

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Narcolepsy is a chronic neurologic state in which patients experience an irrepressible need to sleep or lapses into sleep. The hallmark symptom of narcolepsy is excessive daytime sleepiness, but patients may also experience other symptoms, such as cataplexy, sleep attacks, disturbed nighttime sleep, or sleep-related hallucinations. Narcolepsy has 2 distinct classifications, narcolepsy type 1 and narcolepsy type 2, and only patients with narcolepsy type 1 experience cataplexy. Treatment of narcolepsy must be individualized to patient-specific variables, including symptoms, co-occurring conditions, adverse effects, drug interactions, pregnancy potential, and lifestyle factors. These variables introduce complexities that must be appropriately acknowledged and monitored. Monitoring adverse effects, individualized medication selection, management of key interactions, and care for narcolepsy in patients with reproductive potential are explored through 3 patient cases.

Indexed as

cataplexyexcessive daytime sleepinesshypersomnianarcolepsy

Identifiers

PMID41358039
PMCPMC12681226

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.